Unlike VpreB, CD79b harbors an ITAM in the cytoplasmic domain by which CD79b on the cell surface may promote downstream signaling, irrespective of a fully arranged pre-BCR complex, thereby enhancing the survival and proliferation of BCP-ALL cells. The gene discussed is CD79B; the disease is acute lymphoblastic leukemia.